With this expanded edition you’ll receive:
- 25% More Deal Information
- In-depth Guidance for determining Royalty Rates
- Enhanced Section on Discounted Cash Flow
- New Royalty Rates Derived from Jury Awards in Patent Infringement Cases
- Plus New Tables, Graphs and Much More
This newly updated 2016 reference is derived from all medical device and diagnostics entries from the comprehensive — and more costly — technology edition of this unique benchmarking series. Why? So if your interest is focused primarily on the medical device industry, you can access this valuable data at a much lower price than the larger volume. It’s as simple as that.
Examples of the licensed technologies covered in Royalty Rates for Technology: Medical Device and Diagnostics, 2016 Edition include:
- Drug Delivery Systems
- Imaging Equipment
- Blood Testing and Safety
- Wound Treatment
- Cancer Detection
- Surgical Devices
- Cardiovascular Devices
- And Dozens more…
Act now to get this newly expanded reference including new tables and graphics, 25% more deal data, and an expanded section on calculating royalty rates
This just-released Royalty Rates for Medical Devices & Diagnostics, 2016 Edition provides more royalty rates, an expanded section on royalty rate development, and expert guidance covering royalty audits. Take a look at just some of the details included in this new 2016 edition:
Royalty Rate Data – The royalty rate data from real world transactions and jury awards is expanded by 25% in this new edition. Additional data includes license agreements between independent third parties and from jury awards in patent infringement litigation.
Calculating Royalty Rates – The 2016 Edition also includes expanded guidance on how royalty rates can best be determined. This section addresses topics affecting royalty rates such as exclusivity, naked patents, and licenses that include know-how and upfront payments. Also included is a discussion on how to use a discounted cash flow analysis to determine a royalty rate, as well as guidance on what not to do when determining a royalty rate.
Royalty Audits –You’ll also find in-depth guidance on royalty audits Debora R. Stewart, CPA, and Judy A. Byrd, CPA, of Invotex. The Magnitude and Meaning of Royalty Misreporting provides eye-opening statistics on the incidence of misreported royalties, as well as analysis of the most common reasons for under-reporting, from inadequate definitions in the license agreement and communication failures between the licensing and accounting departments to simple math errors.
Royalty Rates for Medical Devices & Diagnostics, 2016 Edition is a one-of-a-kind resource that reports all available compensation terms from scores of completed medical device license agreements and court decisions, gathered from more than 20 years of research by a highly respected valuation and royalty rate expert. You’ll find all the details on fixed royalty rates, per unit royalties, scaled royalty rates, and license fees. But you get more than just rates and data — you get context as well.
With each transaction you’ll find:
- A description of the licensed technology
- Compensation terms including royalty rates and license fees
- Identity of the licensor and licensee
- Transaction background and history
- Market analysis and benefits of the licensed technology
About the Publisher
Technology Transfer Tactics is proud to partner with IPRA Inc. in bringing this critical reference to our customers. IPRA is a consulting and publishing organization launched in 1993 and headed by founder Russell L. Parr, CFA, ASA, who has over 30 years of consulting experience involving the valuation and pricing of patents, trademarks, copyrights and other intangible assets.
If you need a broader and comprehensive resource covering a wide range of technologies, CLICK HERE for details on Royalty Rates for Technology.